1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Adipocere in 4 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charron, G | 1 |
Doudnikoff, E | 1 |
Laux, A | 1 |
Berthet, A | 1 |
Porras, G | 1 |
Canron, MH | 1 |
Barroso-Chinea, P | 1 |
Li, Q | 1 |
Qin, C | 1 |
Nosten-Bertrand, M | 1 |
Giros, B | 1 |
Delalande, F | 1 |
Van Dorsselaer, A | 1 |
Vital, A | 1 |
Goumon, Y | 1 |
Bezard, E | 1 |
Miklossy, J | 1 |
Doudet, DD | 1 |
Schwab, C | 1 |
Yu, S | 1 |
McGeer, EG | 1 |
McGeer, PL | 1 |
Karunakaran, S | 1 |
Saeed, U | 1 |
Ramakrishnan, S | 1 |
Koumar, RC | 1 |
Ravindranath, V | 1 |
Nyitrai, G | 1 |
Kékesi, KA | 1 |
Dobolyi, A | 1 |
Pungor, K | 1 |
Juhász, G | 1 |
4 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Adipocere
Article | Year |
---|---|
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; alpha-Methyltyrosine; Analysis of Variance; Anim | 2011 |
Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Aged; Aged, 80 and over; Animals; Astrocytes; C | 2006 |
Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Aged; Animals; Brain; Cell Line, Transformed; G | 2007 |
Single low dose of MPTP decreases extracellular levels of noradrenaline and monoamine metabolites in the ventrobasal thalamus of the rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Biogenic Monoamines; Dopamine Ag | 1997 |